CLINICAL_TRIALS
research
· 2026-04-06
Clinical Trial Update: AI-CARE: Artificial Intelligence for Cardiovascular Analysis and Risk Evaluation
Summary
The AI-CARE study from Aiatella Oy is evaluating artificial intelligence-based cardiovascular analysis and risk evaluation in patients with aortic aneurysm diso…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Aiatella Oy | Conditions: Aortic Aneurysm, Aortic Aneurysm Abdominal | Status: RECRUITING